234 related articles for article (PubMed ID: 26447715)
1. Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.
Kasper AM; Ridpath AD; Arnold JK; Chatham-Stephens K; Morrison M; Olayinka O; Parker C; Galli R; Cox R; Preacely N; Anderson J; Kyle PB; Gerona R; Martin C; Schier J; Wolkin A; Dobbs T
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1121-2. PubMed ID: 26447715
[TBL] [Abstract][Full Text] [Related]
2. Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015).
Kasper AM; Ridpath AD; Gerona RR; Cox R; Galli R; Kyle PB; Parker C; Arnold JK; Chatham-Stephens K; Morrison MA; Olayinka O; Preacely N; Kieszak SM; Martin C; Schier JG; Wolkin A; Byers P; Dobbs T
Clin Toxicol (Phila); 2019 Jan; 57(1):10-18. PubMed ID: 29989463
[TBL] [Abstract][Full Text] [Related]
3. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
Law R; Schier J; Martin C; Chang A; Wolkin A;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
[TBL] [Abstract][Full Text] [Related]
4. Notes from the field: Severe illness associated with synthetic cannabinoid use - Brunswick, Georgia, 2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(46):939. PubMed ID: 24257204
[TBL] [Abstract][Full Text] [Related]
5. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
[TBL] [Abstract][Full Text] [Related]
6. Notes from the field: severe illness associated with reported use of synthetic marijuana - Colorado, August-September 2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1016-7. PubMed ID: 24336136
[TBL] [Abstract][Full Text] [Related]
7. Adolescent synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB
Pediatr Emerg Care; 2012 Oct; 28(10):985-9. PubMed ID: 23023462
[TBL] [Abstract][Full Text] [Related]
8. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
9. Synthetic cathinone exposures reported to Texas poison centers.
Forrester MB
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):609-15. PubMed ID: 22541001
[TBL] [Abstract][Full Text] [Related]
10. Acute Poisonings from Synthetic Cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010-2015.
Riederer AM; Campleman SL; Carlson RG; Boyer EW; Manini AF; Wax PM; Brent JA;
MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(27):692-5. PubMed ID: 27413997
[TBL] [Abstract][Full Text] [Related]
11. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB; Haywood T
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
13. An outbreak of synthetic cannabinoid exposures reported to a regional poison center: "K2" identified as 5F-ADB.
Arens AM; Olives TD; Simpson NS; Laes JR; Anderson DL; Bangh SA; Lee SC; Martin S; Banister SD; Gerona RR; Cole JB
Clin Toxicol (Phila); 2019 Jan; 57(1):69-71. PubMed ID: 30430881
[No Abstract] [Full Text] [Related]
14. Synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB; Kleinschmidt K; Schwarz E; Young A
J Addict Dis; 2011 Oct; 30(4):351-8. PubMed ID: 22026527
[TBL] [Abstract][Full Text] [Related]
15. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoid intoxication: a case series and review.
Harris CR; Brown A
J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
[TBL] [Abstract][Full Text] [Related]
17. Notes from the Field: Outbreak of Severe Illness Linked to the Vitamin K Antagonist Brodifacoum and Use of Synthetic Cannabinoids - Illinois, March-April 2018.
Moritz E; Austin C; Wahl M; DesLauriers C; Navon L; Walblay K; Hendrickson M; Phillips A; Kerins J; Pennington AF; Lavery AM; El Zahran T; Kauerauf J; Yip L; Thomas J; Layden J
MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(21):607-608. PubMed ID: 29851941
[No Abstract] [Full Text] [Related]
18. Clinical and financial implications of emergency department visits for synthetic marijuana.
Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
[TBL] [Abstract][Full Text] [Related]
19. The emerging threat of synthetic cannabinoids.
Phillips J; Lim F; Hsu R
Nurs Manage; 2017 Mar; 48(3):22-30. PubMed ID: 28234762
[No Abstract] [Full Text] [Related]
20. Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.
Monte AA; Calello DP; Gerona RR; Hamad E; Campleman SL; Brent J; Wax P; Carlson RG;
J Med Toxicol; 2017 Jun; 13(2):146-152. PubMed ID: 28397128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
